Bill Leonard, the esteemed former director of the Information Security Oversight Office and the principal overseer of the government secrecy system, now has his own blog where readers may look for his views and his insights on secrecy policy as the process of classification reform gets underway in earnest.
The House Judiciary Committee rebuffed a Republican proposal for a “resolution of inquiry” to require the Administration to produce documents concerning the use of Miranda warnings given to detainees captured in Afghanistan. The Committee’s adverse report, dated June 26, is available here.
The Defense Department has issued a newly updated policy statement (pdf) on reporting “questionable” intelligence activities. “It is DoD policy that senior leaders and policymakers within the Government be made aware of events that may erode the public trust in the conduct of DoD intelligence operations,” the June 17, 2009 memorandum states. Some such questionable activities are to be reported to the Intelligence Oversight Board, a component of the President’s Intelligence Advisory Board. However, the efficacy of any such reporting is limited by the fact that that Board currently has no sitting members. (“White House Intel Advisory Board Has No Members,” Secrecy News, June 15, 2009).
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.